Zuzana Traugottova

Statistics

Publications

Citations

141

H-Index

Active since

2023

Affiliations

Pyatigorsk Oncology Center(Current)

Clinvet

Universitair Ziekenhuis Leuven

Tbilisi State Medical University

Sarah Cannon

Zuzana Traugottova is an author at Pyatigorsk Oncology Center specializing in breast cancer hormone therapy, hormone receptor - positive breast cancer, and hormonal cancer therapy.

Publications per year

2023–2024

Publications

Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial

Mafalda Oliveira, Denys Pominchuk, Zbigniew Nowecki et al. · The Lancet Oncology · 2024 · 80 citations

Medicine, Oncology, Pharmacotherapy +17

Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial

Mafalda Oliveira, Denys Pominchuck, Zbigniew Nowecki et al. · Cancer Research · 2023 · 61 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2